About this trial
ORIGINS-VRCE-2 is an observational study aimed to assess how blood vessel forming stem cells from individuals without diabetes or a history of cardiovascular disease differ between individuals of South Asian and European ethnicities. The overarching objective of the study is to investigate whether differential vessel reparative stem cell populations and characteristics may underlie the elevated cardiovascular risk observed among South Asian individuals compared to individuals of European origins.
Eligibility criteria
Qualifiers
Adults 18 years of age or older of South Asian origin or European origin as defined by the following: i. South Asian defined as any individual who identifies as Anglo-Indian, Bangladeshi, Bengali, Bhutanese, Goan, Gujarati, Indian, Jatt, Kashmiri, Maharashtrian, Malayali, Nepali, Pakistani, Punjabi, Sindhi, Sinhalese, Sri Lankan, Tamil, Telugu, or other South Asian origins. ii. European Origin defined as any individual who identifies as from western Europe, northern Europe, southern Europe, eastern Europe or other European origins.
Willing and able to provide written informed consent and comply with study requirements
Must fulfill the following
Disqualifiers
No previous diagnosis of type 2 diabetes
Prior myocardial infarction
Coronary revascularization
Coronary artery disease, peripheral artery disease, cerebrovascular disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Canadian Medical and Surgical Knowledge Translation Research Group
Lead sponsor
Unity Health Toronto
Collaborator
Western University, Canada
Collaborator